# A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

> **NCT00756444** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 67 (actual)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **DRUG:** Panitumumab
- **DRUG:** Cisplatin
- **DRUG:** 5FU

## Key facts

- **NCT ID:** NCT00756444
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-21
- **Primary completion:** 2012-03-30
- **Final completion:** 2012-03-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756444, "A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00756444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*